XML 34 R82.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes - Additional Information (Details) - USD ($)
12 Months Ended
Apr. 30, 2020
Apr. 30, 2019
Apr. 30, 2018
Apr. 30, 2017
Income Tax Disclosure [Line Items]        
Valuation allowance for deferred tax assets $ 225,197,000 $ 92,309,000    
Net operating loss carryforward 208,629,000 84,194,000    
Research and development tax credit carryforwards 15,333,000 3,584,000    
Estimated income tax benefit from CARES Act 3,300,000      
Unrecognized tax benefits 9,706,000 3,870,000 $ 2,019,000 $ 1,196,000
Unrecognized tax benefits that would impact the effective tax rate before consideration of valuation allowance 0      
Unrecognized tax benefit acquired from CARES Act 2,300,000      
Unrecognized tax benefit acquired from research and development tax credits 3,600,000      
Recognize penalties and interests accrued on unrecognized tax benefits 100,000 100,000 $ 200,000  
Accrued interest and penalties, amount 200,000 300,000    
Dividend withholding tax from foreign jurisdictions 800,000      
GILTI provision 500,000      
Canada Revenue Agency        
Income Tax Disclosure [Line Items]        
Research and development tax credit carryforwards $ 600,000      
Research and development tax credit carryforwards, expire date Apr. 30, 2037      
Dutch | Tax and Customs Administration, Netherlands        
Income Tax Disclosure [Line Items]        
Net operating loss carryforward $ 396,200,000      
Net operating loss carryforward, expire date Apr. 30, 2022      
U.S. Federal | IRS        
Income Tax Disclosure [Line Items]        
Net operating loss carryforward $ 490,200,000      
Net operating loss carryforward, expire date Apr. 30, 2031      
Research and development tax credit carryforwards $ 11,300,000      
Research and development tax credit carryforwards, expire date Apr. 30, 2030      
U.S. Federal | Her Majesty's Revenue and Customs (HMRC)        
Income Tax Disclosure [Line Items]        
Net operating loss carryforward $ 18,600,000      
U.S. State Income Tax        
Income Tax Disclosure [Line Items]        
Net operating loss carryforward $ 416,800,000      
Net operating loss carryforward, expire date Apr. 30, 2024      
Research and development tax credit carryforwards $ 1,300,000      
Research and development tax credit carryforwards, expire date Apr. 30, 2022      
The Netherlands        
Income Tax Disclosure [Line Items]        
Valuation allowance for deferred tax assets $ 88,400,000 53,100,000    
Valuation allowance, net deferred tax assets, jurisdictions increased 35,300,000 10,600,000    
United States        
Income Tax Disclosure [Line Items]        
Valuation allowance for deferred tax assets 132,900,000 38,400,000    
Valuation allowance, net deferred tax assets, jurisdictions increased 94,500,000 35,000,000.0    
United Kingdom        
Income Tax Disclosure [Line Items]        
Valuation allowance for deferred tax assets 3,900,000 800,000    
Valuation allowance, net deferred tax assets, jurisdictions increased 3,100,000 $ 800,000    
Non-U.S. Subsidiaries        
Income Tax Disclosure [Line Items]        
Cumulative earnings $ 48,900,000